Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance of Sonazoid Contrast-enhanced Ultrasound in Renal Tumors

NCT04626115 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT04626115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance of Sonazoid Contrast-enhanced Ultrasound in Renal Tumors
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2020
Completion date
August 31, 2021
Enrollment
223 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast enhanced ultrasound